Clinical Trial Update: Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating telavancin versus standard therapy for complicated Gram-positive skin and soft tissue infections has completed and posted results in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abscess
• Cellulitis
• Skin and Soft Tissue Infections
• Wound Infection

Drugs mentioned

• Telavancin (telavancin)

Snippet

Sponsor: Cumberland Pharmaceuticals | Conditions: Infections, Gram-Positive Bacterial, Abscess | Phase 2 | Status: COMPLETED | Results posted: 2010-01-11